These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28682989)

  • 21. [If no-acid, no-heartburn? New physiopathological mechanisms of the gastroesophageal reflux disease].
    Remes-Troche JM; Ramírez-Cervantes KL; Vela MF
    Rev Gastroenterol Mex; 2011; 76(3):237-46. PubMed ID: 22041313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Esophageal hypermotility: cause or effect?
    Crespin OM; Tatum RP; Yates RB; Sahin M; Coskun K; Martin AV; Wright A; Oelschlager BK; Pellegrini CA
    Dis Esophagus; 2016 Jul; 29(5):497-502. PubMed ID: 25893778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.
    Kandulski A; Weigt J; Caro C; Jechorek D; Wex T; Malfertheiner P
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1075-81. PubMed ID: 25496815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional heartburn and non-erosive reflux disease.
    Savarino V; Savarino E; Parodi A; Dulbecco P
    Dig Dis; 2007; 25(3):172-4. PubMed ID: 17827934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased visceral sensitivity, elevated anxiety, and depression levels in patients with functional esophageal disorders and non-erosive reflux disease.
    Losa M; Manz SM; Schindler V; Savarino E; Pohl D
    Neurogastroenterol Motil; 2021 Sep; 33(9):e14177. PubMed ID: 34128293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reflux Hypersensitivity: A New Functional Esophageal Disorder.
    Yamasaki T; Fass R
    J Neurogastroenterol Motil; 2017 Oct; 23(4):495-503. PubMed ID: 28992673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Rome IV versus Rome III criteria for heartburn diagnosis: A comparative study.
    Zhang M; Chen M; Peng S; Xiao Y
    United European Gastroenterol J; 2018 Apr; 6(3):358-366. PubMed ID: 29774149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn.
    Kandulski A; Jechorek D; Caro C; Weigt J; Wex T; Mönkemüller K; Malfertheiner P
    Aliment Pharmacol Ther; 2013 Sep; 38(6):643-51. PubMed ID: 23895770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imipramine for Treatment of Esophageal Hypersensitivity and Functional Heartburn: A Randomized Placebo-Controlled Trial.
    Limsrivilai J; Charatcharoenwitthaya P; Pausawasdi N; Leelakusolvong S
    Am J Gastroenterol; 2016 Feb; 111(2):217-24. PubMed ID: 26753892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and Management of Functional Heartburn.
    Hachem C; Shaheen NJ
    Am J Gastroenterol; 2016 Jan; 111(1):53-61; quiz 62. PubMed ID: 26729546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nonerosive reflux disease-gastroesophageal reflux disease controversy.
    Winter JW; Heading RC
    Curr Opin Gastroenterol; 2008 Jul; 24(4):509-15. PubMed ID: 18622168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survey of findings in patients having persistent heartburn on proton pump inhibitor therapy.
    Mandaliya R; DiMarino AJ; Cohen S
    Dis Esophagus; 2016 Jan; 29(1):27-33. PubMed ID: 25294046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional Gastrointestinal Disorders: Functional Upper Gastrointestinal Disorders in Adults.
    Malone M; Waheed A; Samiullah S
    FP Essent; 2018 Mar; 466():14-20. PubMed ID: 29528205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn.
    Frazzoni M; Conigliaro R; Mirante VG; Melotti G
    Neurogastroenterol Motil; 2012 Feb; 24(2):141-6, e87. PubMed ID: 21988704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esophageal disorders in the elderly.
    Castell DO
    Gastroenterol Clin North Am; 1990 Jun; 19(2):235-54. PubMed ID: 2194944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the different characteristics of sensed reflux events among different heartburn groups.
    Schey R; Shapiro M; Navarro-Rodriguez T; Fass SS; Han B; Wendel C; Fass R
    J Clin Gastroenterol; 2009 Sep; 43(8):699-704. PubMed ID: 18797407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility and acceptability of esophageal-directed hypnotherapy for functional heartburn.
    Riehl ME; Pandolfino JE; Palsson OS; Keefer L
    Dis Esophagus; 2016 Jul; 29(5):490-6. PubMed ID: 25824436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of heartburn.
    Ang D; Sifrim D; Tack J
    Nat Clin Pract Gastroenterol Hepatol; 2008 Jul; 5(7):383-92. PubMed ID: 18542113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional esophageal disorders: pharmacological options.
    Amarasinghe G; Sifrim D
    Drugs; 2014 Aug; 74(12):1335-44. PubMed ID: 25103415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.